Cure SMA issues requests for proposals in three major research areas:
Our basic research program is directed by our Scientific Advisory Board, and our drug discovery program by our Translational Advisory Council—both groups of independent experts who carefully evaluate each proposal for scientific excellence and relevance to the Cure SMA mission.
Cure SMA’s research model is intended to attract industry and government funding for clinical trials. Thus, we do not typically issue RFPs in this area. Instead, we focus on clinical trial readiness, infrastructure, and on connecting researchers with potential study participants.
We fund clinical care research through our Cure SMA Care Center Network, and do not typically issue separate RFPs in this area.
For general questions on our research funding model and RFP process for basic research, drug discovery, and newborn screening, please email [email protected]. For questions on the Cure SMA Care Center Network, please contact [email protected].